anti-ribonucleoprotein antibody ATRC-101
Term · Oncology and biomedicine · MLC-T-ONC-011070
An engineered, human immunoglobulin (Ig) G1 monoclonal antibody directed against a ribonucleoprotein (RNP) complex, with potential immunostimulating and antineoplastic activities. Upon administration, anti-RNP antibody ATRC-101 targets and binds to its RNP complex antigen on tumor cells. This may activate the innate immune system, change the local tumor microenvironment (TME) and promote T-cell-mediated killing of tumor cells. The tumor-restricted RNP complex is expressed in a variety of tumor cells.
| Identifier | MLC-T-ONC-011070 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | anti-RNP antibody ATRC-101 |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-011070",
"term": "anti-ribonucleoprotein antibody ATRC-101",
"field": "Oncology and biomedicine",
"definition": "An engineered, human immunoglobulin (Ig) G1 monoclonal antibody directed against a ribonucleoprotein (RNP) complex, with potential immunostimulating and antineoplastic activities. Upon administration, anti-RNP antibody ATRC-101 targets and binds to its RNP complex antigen on tumor cells. This may activate the innate immune system, change the local tumor microenvironment (TME) and promote T-cell-mediated killing of tumor cells. The tumor-restricted RNP complex is expressed in a variety of tumor cells.",
"synonyms": [
"anti-RNP antibody ATRC-101"
],
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/anti-ribonucleoprotein-antibody-atrc-101/"
}
Record 2,204 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.